Pip, a lymphoid-restricted IRF, contains a regulatory domain that is important for autoinhibition and ternary complex formation with the Ets factor PU.1 - PubMed (original) (raw)
. 1996 Sep 15;10(18):2335-47.
doi: 10.1101/gad.10.18.2335.
Affiliations
- PMID: 8824592
- DOI: 10.1101/gad.10.18.2335
Free article
Pip, a lymphoid-restricted IRF, contains a regulatory domain that is important for autoinhibition and ternary complex formation with the Ets factor PU.1
A L Brass et al. Genes Dev. 1996.
Free article
Abstract
Pip is a lymphoid-restricted IRF transcription factor that is recruited to composite elements within immunoglobulin light-chain gene enhancers through a specific interaction with the Ets factor PU.1. We have examined the transcriptional regulatory properties of Pip as well as the requirements for its interaction with PU.1 and DNA to form a ternary complex. We demonstrate that Pip is a dichotomous regulator; it specifically stimulates transcription in conjunction with PU.1, but represses alpha/beta-interferon-inducible transcription in the absence of PU.1. Thus, during B-cell activation and differentiation, Pip may function both as an activator to promote B cell-specific gene expression and as a repressor to inhibit the antiproliferative effects of alpha/beta-interferons. Mutational analysis of Pip reveals a carboxy-terminal segment that is important for autoinhibition of DNA binding and ternary complex formation. A domain of Pip containing this segment confers autoinhibition and PU.1-dependent binding activity to the DNA-binding domain of the related IRF family member, p48. On the basis of these and other data we propose a model for PU.1/Pip ternary complex formation.
Similar articles
- Assembly requirements of PU.1-Pip (IRF-4) activator complexes: inhibiting function in vivo using fused dimers.
Brass AL, Zhu AQ, Singh H. Brass AL, et al. EMBO J. 1999 Feb 15;18(4):977-91. doi: 10.1093/emboj/18.4.977. EMBO J. 1999. PMID: 10022840 Free PMC article. - Mutation analysis of the Pip interaction domain reveals critical residues for protein-protein interactions.
Ortiz MA, Light J, Maki RA, Assa-Munt N. Ortiz MA, et al. Proc Natl Acad Sci U S A. 1999 Mar 16;96(6):2740-5. doi: 10.1073/pnas.96.6.2740. Proc Natl Acad Sci U S A. 1999. PMID: 10077581 Free PMC article. - Pip, a novel IRF family member, is a lymphoid-specific, PU.1-dependent transcriptional activator.
Eisenbeis CF, Singh H, Storb U. Eisenbeis CF, et al. Genes Dev. 1995 Jun 1;9(11):1377-87. doi: 10.1101/gad.9.11.1377. Genes Dev. 1995. PMID: 7797077 - PU.1/Interferon Regulatory Factor interactions: mechanisms of transcriptional regulation.
Marecki S, Fenton MJ. Marecki S, et al. Cell Biochem Biophys. 2000;33(2):127-48. doi: 10.1385/CBB:33:2:127. Cell Biochem Biophys. 2000. PMID: 11325034 Review. - Immune cell-specific amplification of interferon signaling by the IRF-4/8-PU.1 complex.
Kanno Y, Levi BZ, Tamura T, Ozato K. Kanno Y, et al. J Interferon Cytokine Res. 2005 Dec;25(12):770-9. doi: 10.1089/jir.2005.25.770. J Interferon Cytokine Res. 2005. PMID: 16375605 Review.
Cited by
- Transcriptional control of metabolism by interferon regulatory factors.
Ahmad Z, Kahloan W, Rosen ED. Ahmad Z, et al. Nat Rev Endocrinol. 2024 Oct;20(10):573-587. doi: 10.1038/s41574-024-00990-0. Epub 2024 May 20. Nat Rev Endocrinol. 2024. PMID: 38769435 Free PMC article. Review. - A neomorphic mutation in the interferon activation domain of IRF4 causes a dominant primary immunodeficiency.
Thouenon R, Chentout L, Moreno-Corona N, Poggi L, Lombardi EP, Hoareau B, Schmitt Y, Lagresle-Peyrou C, Bustamante J, André I, Cavazzana M, Durandy A, Casanova JL, Galicier L, Fadlallah J, Fischer A, Kracker S. Thouenon R, et al. J Exp Med. 2023 Jun 5;220(6):e20221292. doi: 10.1084/jem.20221292. Epub 2023 Mar 14. J Exp Med. 2023. PMID: 36917008 Free PMC article. - Adipose tissue macrophages and their role in obesity-associated insulin resistance: an overview of the complex dynamics at play.
Guria S, Hoory A, Das S, Chattopadhyay D, Mukherjee S. Guria S, et al. Biosci Rep. 2023 Mar 31;43(3):BSR20220200. doi: 10.1042/BSR20220200. Biosci Rep. 2023. PMID: 36718668 Free PMC article. Review. - XAF1 prevents hyperproduction of type I interferon upon viral infection by targeting IRF7.
Liu BQ, Liu RB, Li WP, Mao XT, Li YN, Huang T, Wang HL, Chen HT, Zhong JY, Yang B, Chai RJ, Cao Q, Jin J, Li YY. Liu BQ, et al. EMBO Rep. 2023 Jan 9;24(1):e55387. doi: 10.15252/embr.202255387. Epub 2022 Nov 17. EMBO Rep. 2023. PMID: 36394357 Free PMC article. - IRF8: Mechanism of Action and Health Implications.
Moorman HR, Reategui Y, Poschel DB, Liu K. Moorman HR, et al. Cells. 2022 Aug 24;11(17):2630. doi: 10.3390/cells11172630. Cells. 2022. PMID: 36078039 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources